![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » STUDY RESULTS SHOW DIACHROME IMPROVES POORLY-CONTROLLED BLOOD SUGAR LEVELS
STUDY RESULTS SHOW DIACHROME IMPROVES POORLY-CONTROLLED BLOOD SUGAR LEVELS
September 13, 2005
Data from a XLHealth clinical trial demonstrates that adding daily supplementation
with Diachrome to prescription treatment regimens can significantly improve
glycemic control in poorly controlled blood sugar levels in people with Type
2 diabetes. The results of this study were presented at the 41st Annual Meeting
of the European Association for the Study of Diabetes in Athens, Greece.
The randomized, double-blind, placebo-controlled, multicenter 12-week study
was designed to examine the efficacy of Diachrome as an adjunct to medications
in 369 patients with Type 2 diabetes. Study participants taking Diachrome with
one or more antidiabetic medication saw an average range of 0.7-1.9 percent
point reduction in HbA1c (hemoglobin A1c) levels. The study also showed that
insulin resistance was significantly reduced in those taking thiazolidinediones
and Diachrome. There were no adverse reports of hypoglycemia in these patients.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct